[1]
M. Karthick, R. Akkena, and K. Loganathan, “The evolution of active targeting in cancer therapy: bridging molecular biomarkers and intelligent nanomedicine”, BOHR Journal of Pharmaceutical Studies, vol. 4, no. 1, pp. 29–38, Jun. 2026.